4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-25-009837
Chief Financial Officer sold 1,929 shares at $8.89 ($17,149)
- Chief Financial Officer acquired 7,815 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
PISKEL KYLE · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-15 | Grant or award : show line 1 in the form | +7,815 | 279,325 | D | ||
| 2025-05-16 | Sale : show line 2 in the form | −1,929 | $8.89 | $17,149 | 277,396 | D |
| Open-market sales · 1,929 sh · avg $8.89 · $17,149 | ||||||
Loading xslF345X05/form4.xml…